TGF-.BETA. LIGAND TRAP COMPRISED OF TGF-.BETA. RECEPTOR ECTODOMAINS FUSED TO A HUMAN FC DOMAIN (AVID-200)

Malignant Solid Tumor

Bristol-Myers Squibbprotein_peptidePhase 1Dormant

44/ 100

Provisional rating · Methodology v0.2

Rating breakdown

45 Active assets in the Malignant Solid Tumor cohort.

Asset / Sponsor	Phase	Rating
Nivolumab Bristol-Myers Squibb	Phase 2	BB
CIS-DIAMMINEDICHLOROPLATINUM II Genmab	Phase 2	B
Irinotecan Tianjin Medical University Cancer Institute and Hospital	Phase 2	B
IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYPE VEGFR-2 EXTRACELLULAR DOMAIN) (HUMAN MONOCLONAL IMC-1121B .GAMMA.-CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL IMC-1121B .KAPPA.-CHAIN, DIMER Eli Lilly and Company	Phase 2	B
(+)-VINCRISTINE Tianjin Medical University Cancer Institute and Hospital	Phase 2	B

View all 50 →

Order a full diligence report on this asset.

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.